Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Added


Project Scope

This

...

Project team will create a White Paper with recommendations for

...

Treatment Emergent Definitions, with a focus on Phase 2-4 clinical trials.

...

This White Paper will build upon a White Paper that outlines results from a survey on current practices, indicating variation that can likely be reduced.

...

Recommendations will

...

be based on the desired end-in-mind, and may or may not be consistent with current practices.



Project Leads

...

Emails

Mary Nilsson

...

...

William Palo

...

, Abbvie

william.palo@abbvie.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global


Status
colourBlue
titleCurrent Status
Q2 2024

  • Draft white paper was reviewed by the PHUSE office and submitted for public review.



Objectives & Deliverables 

Timelines 

Project team review final White Paper 

Q2 2023
PHUSE Steering Committee & Public Review Q3 2023
Publish White PaperQ4 2023